Topic

Q3 loss

A collection of 1 issue

Nymox Pharmaceutical Corp. Posts Q3 Loss of $716,000

Nymox Pharmaceutical Corp. reports a Q3 loss of $716,000, equivalent to 1 cent per share. Discover the financial performance and insights into the company's future.